Oral COX-2 inhibitors for treating pain

Published on 02 Sep 2019
Last Updated on 02 Sep 2019

Guidance Recommendations

The Ministry of Health's Drug Advisory Committee has recommended:

• celecoxib 200 mg capsule; and

• etoricoxib 60 mg, 90 mg and 120 mg tablets

for treating pain in line with their registered indications in Singapore.

For patients with renal impairment or who have an increased risk of cardiovascular events, clinicians should consider prescribing COX-2 inhibitors at the lowest effective daily dose for the shortest duration possible.

Subsidy status

Celecoxib 200 mg capsule and etoricoxib 60 mg, 90 mg and 120 mg tablets are recommended for inclusion on the MOH Standard Drug List (SDL) for the abovementioned indication.

Oral COX-2 inhibitors for pain (2 Sep 2019) [PDF, 147 KB]

Oral COX-2 inhibitors for pain Plain English Summary (2 Sep 2019) [PDF, 32 KB]